Evidence map›Paper›PMID 32808238›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2021

Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.

Zhe Wang, Peter Ge Kennedy, Cecily Dupree, Min Wang, Catherin Lee, Tiffany Pointon, T Dianne Langford, Michael W Graner, Xiaoli Yu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. EBV Genome Variations and Association With Diseases.Journal of medical virology · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Plasma IgG aggregates as biomarkers for multiple sclerosis.Clinical immunology (Orlando, Fla.) · 2023
    Article
  11. Observational
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. The Possible Role of Neural Cell Apoptosis in Multiple Sclerosis.International journal of molecular sciences · 2022
    Review
  18. Aberrant Immunoglobulin G Glycosylation in Multiple Sclerosis.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Zhe WangNational Engineering Research Center for Protein Drugs, Beijing, 102206, China.
Peter Ge KennedyInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
Cecily DupreeDepartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Min WangImmunoah Therapeutics, Inc., 12635 East Montview Boulevard, Aurora, CO, 80045, USA.
Catherin LeeDepartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Tiffany PointonDepartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
T Dianne LangfordLewis Katz School of Medicine, Temple University, 3500 N. Broad St, Philadelphia, PA, 19140, USA.
Michael W Graner *Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. michael.graner@cuanschutz.edu.ORCID http://orcid.org/0000-0002-3097-0257
Xiaoli Yu *Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. xiaoli.yu@cuanschutz.edu.
University of Colorado Anschutz Medical Campus · USNational Institutes for Food and Drug Control · CNTemple University · USUniversity of Glasgow · GB

Funding

Development of Validation of Phage-Displayed Random Peptide Libraries Technologies for Rapid Isolation and Characterization of Extracellular Vesicles from Patients with Brain TumorsR33MH118174 · NIMH · UNIVERSITY OF COLORADO DENVER · PI GRANER, MICHAEL W., YU, XIAOLI · 2020 to 2022
$1.9M
Development of Validation of Phage-Displayed Random Peptide Libraries Technologies for Rapid Isolation and Characterization of Extracellular Vesicles from Patients with Brain TumorsR21MH118174 · NIMH · UNIVERSITY OF COLORADO DENVER · PI GRANER, MICHAEL W., YU, XIAOLI · 2018 to 2019
$423k
NIMH NIH HHS R21 MH118174NIMH NIH HHS R33 MH118174
6 · The paper itself

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS), the etiology of which is poorly understood. The most common laboratory abnormality associated with MS is increased intrathecal immunoglobulin G (IgG) synthesis and the presence of oligoclonal bands (OCBs) in the brain and cerebrospinal fluid (CSF). However, the major antigenic targets of these antibody responses are unknown. The risk of MS is increased after infectious mononucleosis (IM) due to EBV infection, and MS patients have higher serum titers of anti-EBV antibodies than control populations. Our goal was to identify disease-relevant epitopes of IgG antibodies in MS; to do so, we screened phage-displayed random peptide libraries (12-mer) with total IgG antibodies purified from the brain of a patient with acute MS. We identified and characterized the phage peptides for binding specificity to intrathecal IgG from patients with MS and from controls by ELISA, phage-mediated Immuno-PCR, and isoelectric focusing. We identified two phage peptides that share sequence homologies with EBV nuclear antigens 1 and 2 (EBNA1 and EBNA2), respectively. The specificity of the EBV epitopes found by panning with MS brain IgG was confirmed by ELISA and competitive inhibition assays. Using a highly sensitive phage-mediated immuno-PCR assay, we determined specific bindings of the two EBV epitopes to IgG from CSF from 46 MS and 5 inflammatory control (IC) patients. MS CSF IgG have significantly higher bindings to EBNA1 epitope than to EBNA2 epitope, whereas EBNA1 and EBNA2 did not significantly differ in binding to IC CSF IgG. Further, the EBNA1 epitope was recognized by OCBs from multiple MS CSF as shown in blotting assays with samples separated by isoelectric focusing. The EBNA1 epitope is reactive to MS intrathecal antibodies corresponding to oligoclonal bands. This reinforces the potential role of EBV in the etiology of MS. Graphical abstract Antibodies purified from an MS brain plaque were panned by phage display peptide libraries to discern potential antigens. Phage displaying peptide sequences resembling Epstein-Barr Virus Nuclear Antigens 1 & 2 (EBNA1 & 2) epitopes were identified. Antibodies from sera and CSF from other MS patients also reacted to those epitopes.

Indexed as

Epstein-Barr Virus InfectionsMultiple SclerosisAntibodies, ViralBrainEpitopesEpstein-Barr Virus Nuclear AntigensHerpesvirus 4, HumanHumansOligoclonal BandsAntibodies, ViralEpitopesEpstein-Barr Virus Nuclear AntigensOligoclonal BandsCNSEBNAEpitopeEpstein-Barr virus (EBV)IgG antibodiesMultiple sclerosisOligoclonal bandsPeptidesPhage display

Identifiers

PMID32808238
PMCPMC7431217
OpenAlexW3056092526

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.